The University of Chicago Header Logo

Connection

Robert Naclerio to Adolescent

This is a "connection" page, showing publications Robert Naclerio has written about Adolescent.
Connection Strength

0.572
  1. A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
    View in: PubMed
    Score: 0.055
  2. Diagnostic algorithm for unilateral sinus disease: a 15-year retrospective review. Int Forum Allergy Rhinol. 2015 Jul; 5(7):590-6.
    View in: PubMed
    Score: 0.051
  3. Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
    View in: PubMed
    Score: 0.038
  4. Familial aggregation of nasal conditioning capacity. J Appl Physiol (1985). 2007 Sep; 103(3):1078-81.
    View in: PubMed
    Score: 0.030
  5. Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol. 2006; 139(2):146-8.
    View in: PubMed
    Score: 0.027
  6. Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):223-8.
    View in: PubMed
    Score: 0.025
  7. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med. 2001 Nov 01; 164(9):1640-6.
    View in: PubMed
    Score: 0.020
  8. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
    View in: PubMed
    Score: 0.018
  9. Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
    View in: PubMed
    Score: 0.017
  10. Total IgE serum levels correlate with sinus mucosal thickness on computerized tomography scans. J Allergy Clin Immunol. 1997 Oct; 100(4):563-8.
    View in: PubMed
    Score: 0.015
  11. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
    View in: PubMed
    Score: 0.015
  12. Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg. 1995 Dec; 121(12):1396-402.
    View in: PubMed
    Score: 0.013
  13. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
    View in: PubMed
    Score: 0.013
  14. Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014 Jul-Aug; 28(4):281-6.
    View in: PubMed
    Score: 0.012
  15. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
    View in: PubMed
    Score: 0.012
  16. A pilot study of the effects of intranasal budesonide delivered by NasoNebĀ® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.012
  17. Coronal CT scan abnormalities in children with chronic sinusitis. Laryngoscope. 1993 Sep; 103(9):985-90.
    View in: PubMed
    Score: 0.011
  18. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012 Sep-Oct; 33 Suppl 1:S113-41.
    View in: PubMed
    Score: 0.011
  19. Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
    View in: PubMed
    Score: 0.010
  20. Microbiology of chronic sinusitis in children. Arch Otolaryngol Head Neck Surg. 1991 Sep; 117(9):980-3.
    View in: PubMed
    Score: 0.010
  21. Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
    View in: PubMed
    Score: 0.009
  22. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Nov-Dec; 31(6):483-92.
    View in: PubMed
    Score: 0.009
  23. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):155-61.
    View in: PubMed
    Score: 0.009
  24. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.
    View in: PubMed
    Score: 0.009
  25. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy. 1989 Nov; 63(5):465-9.
    View in: PubMed
    Score: 0.009
  26. A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope. 2008 Nov; 118(11):2067-72.
    View in: PubMed
    Score: 0.008
  27. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr; 63 Suppl 86:8-160.
    View in: PubMed
    Score: 0.008
  28. A genome-wide screen for hyposmia susceptibility Loci. Chem Senses. 2008 Apr; 33(4):319-29.
    View in: PubMed
    Score: 0.008
  29. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
    View in: PubMed
    Score: 0.007
  30. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.007
  31. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006 Feb; 132(2):164-72.
    View in: PubMed
    Score: 0.007
  32. Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
    View in: PubMed
    Score: 0.007
  33. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
    View in: PubMed
    Score: 0.006
  34. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct; 128(4):597-602.
    View in: PubMed
    Score: 0.006
  35. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
    View in: PubMed
    Score: 0.005
  36. A retrospective analysis of the intact canal wall tympanoplasty with mastoidectomy. Am J Otol. 1981 Apr; 2(4):315-7.
    View in: PubMed
    Score: 0.005
  37. Location and gross morphology of the nasopalatine duct in human adults. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):741-8.
    View in: PubMed
    Score: 0.005
  38. Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):585-90.
    View in: PubMed
    Score: 0.004
  39. CD4+ lymphocytes are increased in the sinus mucosa of children with chronic sinusitis. Arch Otolaryngol Head Neck Surg. 1996 Oct; 122(10):1071-6.
    View in: PubMed
    Score: 0.004
  40. Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol. 1994 Jul; 11(1):108-13.
    View in: PubMed
    Score: 0.003
  41. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992 Sep; 118(9):940-3.
    View in: PubMed
    Score: 0.003
  42. A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar; 31(3):287-94.
    View in: PubMed
    Score: 0.002
  43. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
    View in: PubMed
    Score: 0.002
  44. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.002
  45. Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
    View in: PubMed
    Score: 0.002
  46. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
    View in: PubMed
    Score: 0.002
  47. Endoscopic middle meatal antrostomy: theory, technique, and patency. Laryngoscope. 1987 Aug; 97(8 Pt 3 Suppl 43):1-9.
    View in: PubMed
    Score: 0.002
  48. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
    View in: PubMed
    Score: 0.002
  49. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
    View in: PubMed
    Score: 0.002
  50. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
    View in: PubMed
    Score: 0.002
  51. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.002
  52. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
    View in: PubMed
    Score: 0.001
  53. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.